NASDAQ: ISPC
Ispecimen Inc Stock Ownership - Who owns Ispecimen?

Insider buying vs selling

Have Ispecimen Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ISPC insiders and whales buy or sell their stock.

ISPC Shareholders

What type of owners hold Ispecimen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Andrew L. Ross40.44%3,951,388$711.25kInsider
George H. Scholl8.65%845,106$152.12kInsider
Obf Investments LLC8.62%841,981$151.56kInsider
Christopher Ianelli4.35%425,359$76.56kInsider
Jill Mullan2.52%246,226$44.32kInsider
Benjamin Bielak0.86%84,348$15.18kInsider
Tracy Curley0.51%49,541$8.92kInsider
Geode Capital Management LLC0.43%41,594$7.49kInstitution
Vanguard Group Inc0.30%29,407$5.29kInstitution
Susquehanna International Group LLP0.15%15,063$2.71kInstitution

1 of 3

ISPC vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ISPC1.30%66.08%
QUCY28.15%44.56%Net Buying
BNBX2.37%97.63%
NDRA5.33%94.67%Net Buying
ADVB4.08%0.00%

Ispecimen Stock Ownership FAQ

Who owns Ispecimen?

Ispecimen (NASDAQ: ISPC) is owned by 1.30% institutional shareholders, 66.08% Ispecimen insiders, and 32.62% retail investors. Andrew L. Ross is the largest individual Ispecimen shareholder, owning 3.95M shares representing 40.44% of the company. Andrew L. Ross's Ispecimen shares are currently valued at $600.61k.

If you're new to stock investing, here's how to buy Ispecimen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.